Steven Cohen’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Steven Cohen’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,031,371	Closed	-$27.9M	–	2430
2024 Q2	$27.9M	Sell	1,031,371 -343,629	-25%	-$6.78M	0.07%	325
2024 Q1	$29.7M	Buy	1,375,000 +550,000	+67%	+$12M	0.07%	325
2023 Q4	$4.97M	Hold	825,000	–	–	0.01%	927
2023 Q3	$4.59M	Hold	825,000	–	–	0.01%	902
2023 Q2	$6.06M	Sell	825,000 -425,000	-34%	-$3.22M	0.02%	748
2023 Q1	$5.01M	Buy	+1,250,000	New	+$6.1M	0.02%	752

Other funds holding LBPH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Steven Cohen's LBPH Position: Q3 2024 in Review

Steven Cohen sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q3 2024, closing a stake of 1,031,371 shares — an estimated $27.9M sold.

Steven Cohen first reported a position in LBPH in Q1 2023 and held it in 6 quarters. The position peaked at $29.7M in Q1 2024. 125 funds tracked by Wall St. Rank hold LBPH as of Q3 2024.

Steven Cohen reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Steven Cohen sold 1,031,371 Longboard Pharmaceuticals, Inc. Common Stock shares in Q3 2024, an estimated $27.9M.
Steven Cohen first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 6 quarters.
Steven Cohen's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $29.7M in Q1 2024.
125 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q3 2024.

Based on Point72 Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.